-
Ocuphire Pharma Stock Is Trading Higher After Nyxol Aces Late-Stage Study
Monday, March 15, 2021 - 6:38am | 311Ocuphire Pharma Inc (NASDAQ: OCUP) stock is soaring in the premarket in reaction to positive data from MIRA-2 Phase 3 trial evaluating Nyxol. Nyxol is an eye drop formulation of phentolamine mesylate designed to reverse pharmacologically induced mydriasis (dilation of...